BioAI and Arbele Bio partner for AI-powered oncology clinical trials
BioAI Announces Strategic Partnership with Arbele Bio to advance Predictive AI-Models in Oncology Clinical Trials MANCHESTER, N.H., Sept....
MeMed BV test reduces antibiotic overuse in first US interventional trial
MeMed BV Test Demonstrates Antibiotic Overuse Reduction in First US Interventional Trial —First Multi-Center Randomized Controlled...
CSL & Arcturus: sa-mRNA COVID Vaccine Superior to Comirnaty
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination...
RedHill Announces New U.S. Coronavirus Patent for Opaganib, Valid Through 2041
RedHill Announces New U.S. Coronavirus Patent for Opaganib, Valid Through 2041 New U.S. patent issued covering the identification of a...
Talicia® Named First-Line H. pylori Treatment in New ACG Guidelines
RedHill’s Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines First new American...
Palatin Updates on Clinical Programs, Priorities, and Milestones
Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones CRANBURY, N.J. , Sept. 9,...
Pioneering Toys & Games Earn First-Ever MESH Accreditation
Pioneering Toys & Games Recognized with First-Ever MESH Accreditation ALEXANDRIA, Va., Sept. 9, 2024 /PRNewswire/ — As families...
Lunit Partners with Roche to Advance Cancer Biomarker Testing
Lunit Joins Roche’s Digital Pathology Open Environment to Advance Cancer Biomarker Testing SEOUL, South Korea, Sept. 9,...
Exactech Unveils AI Breakthroughs in Shoulder, Knee & Ankle Tech
Exactech Unveils Pioneering AI and Radiomics Research for Shoulder Arthroplasty, Highlights Advances in Knee and Ankle Technologies...
Hamamatsu Launches CYTOQUBE: Fast 3D Cell Analyzer System
Hamamatsu Photonics introduces CYTOQUBE, a new cell analyzer combining light-sheet optics and image analysis in a fast, user-friendly...
